Literature DB >> 11091277

The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.

M Soto1, C Alonso, J M Requena.   

Abstract

The acidic ribosomal proteins of the protozoan parasite Leishmania infantum have been described as prominent antigens during both human and canine visceral leishmaniasis. In this study we present data showing that the intraperitoneal administration in BALB/c mice of the Leishmania LiP2a protein, in the absence of any added adjuvants, elicited a strong humoral response as an indication that the protein is a potent immunogen. Despite the evolutionary conservation of the acidic ribosomal proteins, the antibody response was found to be specific for the Leishmania protein. Another remarkable finding was the observation that the LiP2a protein stimulates the in vitro proliferation of splenocytes from either LiP2a-immunized or naive BALB/c mice. Since similar proliferative indices were observed in T cell-enriched cultures, it is likely that the LiP2a stimulating activity is due mainly to T lymphocyte expansion. Also, the stimulatory effect was demonstrated to be antigen-specific, since the proliferation was abrogated by the presence of anti-LiP2a antibodies. Interestingly, the LiP2a protein stimulated the production of substantial amounts of IFN-gamma in cultured splenocytes from LiP2a-immunized mice. Our data indicate therefore that the immunostimulatory properties shown by this antigen should be taken into account when developing therapeutic and prophylactic vaccines against leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091277      PMCID: PMC1905769          DOI: 10.1046/j.1365-2249.2000.01372.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

Authors:  Z J Pan; C J Anderson; H A Stafford
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The gene for a T lymphocyte triggering factor from African trypanosomes.

Authors:  T Vaidya; M Bakhiet; K L Hill; T Olsson; K Kristensson; J E Donelson
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

4.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 5.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Genomic organization and expression of two independent gene arrays coding for two antigenic acidic ribosomal proteins of Leishmania.

Authors:  M Soto; J M Requena; M Garcia; L C Gómez; I Navarrete; C Alonso
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity.

Authors:  M J Levin; M Vazquez; D Kaplan; A G Schijman
Journal:  Parasitol Today       Date:  1993-10

9.  A cDNA clone coding for a novel allergen, Cla h III, of Cladosporium herbarum identified as a ribosomal P2 protein.

Authors:  L Zhang; G Muradia; I H Curran; H Rode; H M Vijay
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

10.  During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins.

Authors:  M Soto; J M Requena; L Quijada; S O Angel; L C Gomez; F Guzman; M E Patarroyo; C Alonso
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more
  3 in total

1.  Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination.

Authors:  Barbara Papadopoulou; Gaétan Roy; Marie Breton; Christoph Kündig; Carole Dumas; Isabelle Fillion; Ajay K Singh; Martin Olivier; Marc Ouellette
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.

Authors:  S Iborra; D R Abánades; N Parody; J Carrión; R M Risueño; M A Pineda; P Bonay; C Alonso; M Soto
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

3.  Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.

Authors:  Rory C F Brito; Frederico G Guimarães; João P L Velloso; Rodrigo Corrêa-Oliveira; Jeronimo C Ruiz; Alexandre B Reis; Daniela M Resende
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.